Golan Bitton
Chief Executive Officer chez UNIVO PHARMACEUTICALS LTD
Provenance du réseau au premier degré de Golan Bitton
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 36 | |
UNV Medicine Ltd.
 UNV Medicine Ltd. BiotechnologyHealth Technology UNV Medicine Ltd. engages in the development and marketing of medical marijuana products. The company was founded by Golan Bitton on November 24, 2016 and is headquartered in Ashkelon, Israel.
4
| Subsidiary | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Golan Bitton via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Director/Board Member | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ALARUM TECHNOLOGIES LTD. | Information Technology Services | Chairman | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Chairman Corporate Officer/Principal | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Investor Relations Contact Director/Board Member Corporate Secretary Director/Board Member Chief Executive Officer | |
| DROR ORTHO-DESIGN, INC. | Computer Peripherals | Chairman | |
| SOL-GEL TECHNOLOGIES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Graduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
| MY SIZE, INC. | Internet Software/Services | Director/Board Member Chief Executive Officer | |
| Bar-Ilan University | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Ben-Gurion University of the Negev | College/University | Doctorate Degree Undergraduate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Israel Bar Association
 Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GEFFEN RESIDENCE & RENEWAL LTD | Agricultural Commodities/Milling | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Chairman Director/Board Member General Counsel Director/Board Member Director/Board Member | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Director/Board Member Chairman | |
| XYLO TECHNOLOGIES LTD | Medical Specialties | Director/Board Member Director/Board Member | |
| BIOLIGHT LIFE SCIENCES LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
Teva Pharmaceuticals Europe BV
 Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | Miscellaneous | Chief Executive Officer | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| EXALENZ BIOSCIENCE LTD | Medical Specialties | Investor Relations Contact Director/Board Member | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| POLYPID LTD. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| CANZON ISRAEL LTD | Internet Software/Services | Director/Board Member Chief Executive Officer | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Undergraduate Degree | |
Israel Diamond Manufacturers Association Ltd.
 Israel Diamond Manufacturers Association Ltd. Miscellaneous Commercial ServicesCommercial Services Israel Diamond Manufacturers Association Ltd. engages in the advancement of the diamonds industry and the unification of diamonds producers. The company was founded in 1940 and is headquartered in Ramat Gan, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| HAGAG GROUP REAL ESTATE ENTREPRENEURSHIP LTD | Real Estate Development | Director/Board Member | |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Biotechnology | Director/Board Member | |
| CH Health | Chief Executive Officer | ||
| The Institute for the Advancement of Education in Jaffa | Chairman | ||
Pi-Cardia Ltd.
 Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | Medical Specialties | Director/Board Member Director/Board Member | |
Emerald Medical Applications Ltd.
 Emerald Medical Applications Ltd. Medical SpecialtiesHealth Technology Emerald Medical Applications Ltd. was engaged in the provision of medical apparatus software solutions. The company was founded by Adi Zamir and Lior Wayn on February 17, 2010 and was headquartered in Modi'in-Maccabim-Re'ut, Israel. | Medical Specialties | Director/Board Member | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
| VIEWBIX INC. | Computer Peripherals | Director/Board Member | |
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| NRX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Israël | 35 |
| Etats-Unis | 7 |
| Royaume-Uni | 3 |
| Pays-Bas | 2 |
| France | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 8 |
| Finance | 5 |
| Technology Services | 4 |
| Electronic Technology | 3 |
Opérationnelle
| Director/Board Member | 181 |
| Independent Dir/Board Member | 43 |
| Chairman | 42 |
| Corporate Officer/Principal | 31 |
| Chief Executive Officer | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Aharon Schwartz | 29 |
| Tamar Kfir | 26 |
| Chaim Hurvitz | 25 |
| Ruben Krupik | 23 |
| Gil Bianco | 23 |
| David Grossman | 22 |
| Assaf Segal | 19 |
| Samuel Rubinstein | 17 |
| Yacov Nimkovsky | 16 |
| Jan Leschly | 16 |
| Max Herzberg | 14 |
| Eli Cohen | 12 |
| Joshua Levine | 10 |
| Joseph Schwarz | 8 |
| Ofra Yamin | 8 |
- Bourse
- Insiders
- Golan Bitton
- Connexions Sociétés
